{"protocolSection":{"identificationModule":{"nctId":"NCT05321225","orgStudyIdInfo":{"id":"BBBD-AIS"},"organization":{"fullName":"Capital Medical University","class":"OTHER"},"briefTitle":"The Level of Blood Brain Barrier Damage Biomarker in Acute Ischemic Stroke","officialTitle":"The Level of Blood Brain Barrier Damage Biomarker Predicting Hemorrhagic Transformation Following Acute Ischemic Stroke"},"statusModule":{"statusVerifiedDate":"2022-04","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2022-03-10","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-03-10","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2022-03-19","studyFirstSubmitQcDate":"2022-04-01","studyFirstPostDateStruct":{"date":"2022-04-11","type":"ACTUAL"},"lastUpdateSubmitDate":"2022-04-10","lastUpdatePostDateStruct":{"date":"2022-04-15","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR_INVESTIGATOR","investigatorFullName":"Ji Xunming,MD,PhD","investigatorTitle":"Professor of Neurosurgery, Vice-President of Xuan Wu Hospital","investigatorAffiliation":"Capital Medical University"},"leadSponsor":{"name":"Ji Xunming,MD,PhD","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"Hemorrhagic transformation is a common complication of acute ischemic stroke patients . BBB damage is regarded as a major pathophysiological mechanism of hemorrhagic transformation. So, the investigators hypothesis the level of BBB damage biomarker is predictor of intracranial hemorrhage following ischemic stroke.","detailedDescription":"Hemorrhagic transformation is a common complication of acute ischemic stroke patients . BBB injury often occurs in the early stage of ischemic stroke, leading brain tissue edema or even hemorrhagic transformation with the development of ischemic injury. The biomarker of BBB damage, such as the level of serum occludin, can reflect the extent of BBB injury. So, the investigators hypothesis the level of BBB damage biomarker is predictor of intracranial hemorrhage following ischemic stroke."},"conditionsModule":{"conditions":["Ischemic Stroke"],"keywords":["blood brain barrier","hemorrhagic transformation","ischemic stroke"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":true,"targetDuration":"3 Years","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"bioSpec":{"retention":"SAMPLES_WITHOUT_DNA","description":"Blood samples from enrolled patients on admission was drawn by emergency department nurse using containing coagulant tubes."},"enrollmentInfo":{"count":1000,"type":"ESTIMATED"}},"armsInterventionsModule":{"interventions":[{"type":"DIAGNOSTIC_TEST","name":"the level of biomarker in bood","description":"Elisa is used to test the level of biomarker in blood."}]},"outcomesModule":{"primaryOutcomes":[{"measure":"The change of serum biomarkers within 72h in ischemic stroke patients","description":"The level of biomarkers are detected using Elisa(Enzyme Linked Immunosorbent Assay)，biomarkers including Occludin(ng/mL), Claudin-5(ng/mL), MMP-2/9(ng/mL)，c-Fn(ug/mL), ZO-1(pg/mL), vWF(ng/mL), IL-2RA(ng/mL), CCL16(ng/mL), CNTN(ng/mL), SELE(ng/mL) and PGLYRP1(ng/mL).","timeFrame":"Day 0, Day 1, Day 2, Day 3."}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Enrolled patients aged 18-80years.\n2. Acute ischemic stroke\n3. Informed consent obtained.\n\nExclusion Criteria:\n\n1. Tumor stroke or hemorrhagic stroke or hemorrhagic cerebral infarction on admission.\n2. Stroke or serious head trauma within the previous 3 months\n3. inflammatory or infectious diseases, cancer, coagulation disturbance disease and severe renal and liver failure\n4. blood sample occurred hemolysis or cloudy.\n5. Incomplete clinical data\n6. Platelet count of less than 100,000 per cubic millimeter\n7. Received oral anticoagulation therapy preceding the onset of stroke and INR greater than 1.7 or prothrombin times greater than 15 seconds\n8. Pregnant or breast-feeding women\n9. Patients being enrolled or having been enrolled in other clinical trial -","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Acute ischemic stroke patients received standard therapy within 24-hour since stroke onset","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"xunming ji, MD PhD","role":"CONTACT","phone":"86-10-83198952","email":"jixunming@vip.163.com"},{"name":"Zhifeng Qi, PhD","role":"CONTACT","phone":"86-10-83199236","email":"qizhifeng@xwh.ccmu.edu.cn"}],"overallOfficials":[{"name":"Ke Jian Liu, PhD","affiliation":"Xuan Wu Hospital,Capital Medical University","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Xuanwu hospital;Capital Medical University","status":"RECRUITING","city":"Beijin","state":"XI Cheng District","zip":"100053","country":"China","contacts":[{"name":"Xunming Ji","role":"CONTACT","phone":"+86-10-83198952","email":"jixunming@vip.163.com"}]}]},"ipdSharingStatementModule":{"ipdSharing":"YES"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}